Translating Next-Generation Science Into Transformative Gene TherapiesLearn About Our Programs

Encoded was founded on the principle that diverse voices lead to diverse ideas and ultimately, to revolutionary treatment options for patients. Our diversity – whether gender, ethnicity, sexual …

October 09, 2025 New Preclinical Data from Encoded Therapeutics Demonstrate Therapeutic Potential of its One-time, Non-opioid Gene Therapy Candidate for Chronic Pain September 02, …

Encoded offers competitive pay, an equity program and benefits. We provide the support that team members need at work to succeed, and we give back the benefits and perks to maintain …

Programs Encoded is building an internally developed pipeline of best- and potentially first-in-class therapies focused on central nervous system (CNS) disorders.

Encoded carefully designs clinical studies to assess safety and efficacy of its investigational gene therapies for the treatment of pediatric CNS disorders. People considering enrolling their child …

Encoded is developing ETX101, a potential one-time, disease-modifying gene regulation therapy for SCN1A+ Dravet syndrome. ETX101, Encoded’s lead program, is specifically designed to …

Harnessing our proprietary technology platform and expertise, we can efficiently advance programs from discovery through clinical development. Encoded is committed to pioneering …

Contact Directory Patients Community and Clinical Trials [email protected] Healthcare Providers [email protected] Media [email protected] …

Ever wondered what it takes to make a gene therapy? Join us on a virtual lab tour at Encoded’s headquarters in South San Francisco. Meet a few of our talented scientists ready to explain …